Market News

Dr Reddys Share Price Live Updates: Dr. Reddy's Laboratories closed at Rs 1275.4 yesterday.

Dr Reddys Share Price Live Updates: Dr. Reddy's Laboratories shows strong market interest

Dr. Reddy's Labs oncology drug Bosutinib Tablets in United States

Dr. Reddy's Laboratories has announced the first-to-market launch of Bosutinib Tablets 400 mg, a generic equivalent of Bosulif, in the United States, expanding its oncology portfolio.

Dr Reddy's launches cancer drug Bosutinib used for treatment of Chronic Myeloid Leukaemia

Dr Reddy's launches Bosutinib Tablets 400mg, a generic of Bosulif, in the US with MSN Laboratories, holds exclusive US marketing rights, shares down 0.24 percent Friday

Dr Reddys Share Price Live Updates: Dr. Reddy's Laboratories experiences a downturn in returns.

Buy, Sell Or Hold: IRCTC, SBI, Hindustan Copper, M&M, Paras Defence, Dr Reddy's Laboratories — Ask Profit

Buy Sell Hold

Dr Reddys Share Price Live Updates: Dr. Reddy's Laboratories faces a monthly return setback

Dr Reddys Share Price Live Updates: Dr. Reddy's Laboratories trading volume highlights

Dr Reddys Share Price Live Updates: Dr. Reddy's Laboratories weekly performance shows decline

Dr Reddys Share Price Live Updates: Dr. Reddy's Laboratories shows low beta, indicating stability.

Dr Reddys Share Price Live Updates: Dr. Reddy's Laboratories trading volume report

Dr Reddys Share Price Live Updates: Dr. Reddy's Laboratories faces a minor setback in weekly returns